Bank of New York Mellon’s HCA Healthcare HCA Stock Holding History
Bought
Maintained
Sold
Other funds holding HCA
Bank of New York Mellon's HCA Position: Q2 2026 in Review
Bank of New York Mellon reduced its HCA Healthcare (HCA) stake by 4.8% in Q2 2026, selling an estimated $19.3M and leaving 898,612 shares worth $350M. The position accounts for 0.06% of the portfolio, ranked #285.
Bank of New York Mellon first reported a position in HCA in Q2 2013 and has held it in 53 quarters since. The position peaked at $643M in Q4 2021. 979 funds tracked by Wall St. Rank hold HCA as of Q2 2026.
- Bank of New York Mellon held 898,612 shares of HCA Healthcare worth $350M as of Q2 2026.
- Bank of New York Mellon sold 45,619 HCA Healthcare shares in Q2 2026, an estimated $19.3M.
- HCA Healthcare made up 0.06% of Bank of New York Mellon's portfolio in Q2 2026, its #285 holding.
- Bank of New York Mellon first reported a position in HCA Healthcare in Q2 2013 and has held it in 53 quarters since.
- Bank of New York Mellon's HCA Healthcare position peaked at $643M in Q4 2021.
- 979 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.
Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.